Market Place
Sourcing Support
Atlas Signs Agreement to Acquire a Controlling Interest in Three Pharmacies
24 May 2023 //
GLOBENEWSWIRE
Biogeneration Ventures raises $119M for new fund, adding a personal record
24 Jun 2020 //
ENDPTS
Noxxon Announces Issuance of Convertible Bonds Under Agreement With Atlas
12 Jun 2020 //
BUSINESSWIRE
For a post-Soliris world, Atlas-backed Q32 Bio outlines $46M next-gen
27 May 2020 //
ENDPTS
Horizon Discovery Partners With the Human Protein Atlas
03 Dec 2019 //
BUSINESS WIRE
Atlas gene therapy startup Avrobio files for $86M IPO
29 May 2018 //
FIERCE BIOTECH
RNA splicing mutations occur in more cancers than we thought
03 Apr 2018 //
FIERCE PHARMA
Atlas, Amgen, Lilly back Kymera’s $30M series A
30 Oct 2017 //
FIERCE BIOTECH
US FDA Issues Form 483 to Atlas Pharmaceuticals, LLC
27 Oct 2017 //
FDA
FDA Form 483 For Atlas Pharmaceuticals
18 Oct 2017 //
FDA
Shooting for Ph3, Spero tees up a antibiotic in-licensed cheap lines up $86M IPO
11 Oct 2017 //
ENDPTS
Biotech scientist/entrepreneur Saurabh Saha makes an unusual return
10 Oct 2017 //
ENDPTS
Atlas Venture vows to keep doing well by doing good new, $350M biotech fund
29 Jun 2017 //
ENDPTS
Atlas Pharms LLC`s Generic Methocarbamol Receives Approval In US
08 Feb 2017 //
FDA
Sofinnova, Atlas lead next-gen autoimmune upstart’s $35M Series A
15 Sep 2016 //
FIERCE BIOTECH
Atlas` new immuno-oncology biotech recruits an AstraZeneca vet to take the reins
07 May 2015 //
FIERCE BIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.